Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.
Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation of trial results and hindered evaluation of potentially efficacious HIV prevention gels. Understanding the underlying reasons why women join trials and their barriers to product use can support identif...
Main Authors: | Lori Miller, Neetha Morar, Saidi Kapiga, Gita Ramjee, Richard Hayes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0244652 |
Similar Items
-
Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa
by: Mantell Joanne E, et al.
Published: (2007-03-01) -
Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
by: Lori Miller, et al.
Published: (2022-01-01) -
Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania
by: Soteli Selephina, et al.
Published: (2009-10-01) -
Ethical considerations in implementing a biometric coenrolment prevention system in clinical trials in South Africa
by: Jayajothi Moodley, et al.
Published: (2016-05-01) -
Phase III microbicide trial methodology: opinions of experienced expanded safety trial participants in South Africa
by: Janneke van de Wijgert, et al.
Published: (2005-11-01)